{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:28:54Z","timestamp":1724891334345},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,28]]},"DOI":"10.7759\/cureus.67984","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:01:44Z","timestamp":1724828504000},"source":"Crossref","is-referenced-by-count":0,"title":["Analysis of Salivary Neuropeptides in Anxiety and Depression Using the Luminex MAGPIX\u00ae System"],"prefix":"10.7759","author":[{"given":"Ida","family":"Kupcova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubos","family":"Danisovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sona","family":"Bernatova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Harsanyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Depressive disorder (depression). (2023). Accessed. July 10, 2024: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression."},{"key":"ref2","unstructured":"Global health data exchange (GHDx). (2022). Accessed. July 10, 2024: https:\/\/ghdx.healthdata.org\/."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.05.003","article-title":"A systematic review and meta-regression of the prevalence and incidence of perinatal depression","volume":"219","author":"Woody CA","year":"2017","unstructured":"Woody CA, Ferrari AJ, Siskind DJ, Whiteford HA, Harris MG. A systematic review and meta-regression of the prevalence and incidence of perinatal depression. J Affect Disord. 2017, 219:86-92. 10.1016\/j.jad.2017.05.003","journal-title":"J Affect Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291717003336","article-title":"Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys","volume":"48","author":"Evans-Lacko S","year":"2018","unstructured":"Evans-Lacko S, Aguilar-Gaxiola S, Al-Hamzawi A, et al.. Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys. Psychol Med. 2018, 48:1560-71. 10.1017\/S0033291717003336","journal-title":"Psychol Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/bs12080262","article-title":"Anxiety and depression: what do we know of neuropeptides?","volume":"12","author":"Kupcova I","year":"2022","unstructured":"Kupcova I, Danisovic L, Grgac I, Harsanyi S. Anxiety and depression: what do we know of neuropeptides?. Behav Sci (Basel). 2022, 12:262. 10.3390\/bs12080262","journal-title":"Behav Sci (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1180720","article-title":"Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function","volume":"14","author":"Yu H","year":"2023","unstructured":"Yu H, Ni P, Zhao L, et al.. Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function. Front Psychiatry. 2023, 14:1180720. 10.3389\/fpsyt.2023.1180720","journal-title":"Front Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2018.11.011","article-title":"The endogenous oxytocin system in depressive disorders: a systematic review and meta-analysis","volume":"101","author":"Engel S","year":"2019","unstructured":"Engel S, Laufer S, Knaevelsrud C, Schumacher S. The endogenous oxytocin system in depressive disorders: a systematic review and meta-analysis. Psychoneuroendocrinology. 2019, 101:138-49. 10.1016\/j.psyneuen.2018.11.011","journal-title":"Psychoneuroendocrinology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2017.11.006","article-title":"De-masking oxytocin-deficiency in craniopharyngioma and assessing its link with affective function","volume":"88","author":"Gebert D","year":"2018","unstructured":"Gebert D, Auer MK, Stieg MR, et al.. De-masking oxytocin-deficiency in craniopharyngioma and assessing its link with affective function. Psychoneuroendocrinology. 2018, 88:61-9. 10.1016\/j.psyneuen.2017.11.006","journal-title":"Psychoneuroendocrinology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/08039488.2018.1554698","article-title":"Assessing the relationship between attachment, parental attitude and plasma oxytocin in schizophrenia patients and their unaffected siblings","volume":"73","author":"Ayd\u0131n O","year":"2019","unstructured":"Ayd\u0131n O, Bal\u0131k\u00e7\u0131 K, Ta\u015f C, \u00dcnal-Ayd\u0131n P, Taneli F, Esen-Danac\u0131 A. Assessing the relationship between attachment, parental attitude and plasma oxytocin in schizophrenia patients and their unaffected siblings. Nord J Psychiatry. 2019, 73:51-7. 10.1080\/08039488.2018.1554698","journal-title":"Nord J Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-022-02543-5","article-title":"Association between salivary oxytocin levels and the amygdala and hippocampal volumes","volume":"227","author":"Shou Q","year":"2022","unstructured":"Shou Q, Yamada J, Nishina K, Matsunaga M, Matsuda T, Takagishi H. Association between salivary oxytocin levels and the amygdala and hippocampal volumes. Brain Struct Funct. 2022, 227:2503-11. 10.1007\/s00429-022-02543-5","journal-title":"Brain Struct Funct"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0027","article-title":"Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases","volume":"29","author":"Brzoska T","year":"2008","unstructured":"Brzoska T, Luger TA, Maaser C, Abels C, B\u00f6hm M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev. 2008, 29:581-602. 10.1210\/er.2007-0027","journal-title":"Endocr Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2008.06.009","article-title":"Role of alpha-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation","volume":"29","author":"Lasaga M","year":"2008","unstructured":"Lasaga M, Debeljuk L, Durand D, Scimonelli TN, Caruso C. Role of alpha-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation. Peptides. 2008, 29:1825-35. 10.1016\/j.peptides.2008.06.009","journal-title":"Peptides"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01074-x","article-title":"\u03b1-MSH-catabolic enzyme prolylcarboxypeptidase in nucleus accumbens shell ameliorates stress susceptibility in mice through regulating synaptic plasticity","volume":"44","author":"Deng Q","year":"2023","unstructured":"Deng Q, Zhang SQ, Yang PF, Dong WT, Wang F, Long LH, Chen JG. \u03b1-MSH-catabolic enzyme prolylcarboxypeptidase in nucleus accumbens shell ameliorates stress susceptibility in mice through regulating synaptic plasticity. Acta Pharmacol Sin. 2023, 44:1576-88. 10.1038\/s41401-023-01074-x","journal-title":"Acta Pharmacol Sin"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110367726","article-title":"Opioids and anxiety","volume":"25","author":"Colasanti A","year":"2011","unstructured":"Colasanti A, Rabiner EA, Lingford-Hughes A, Nutt DJ. Opioids and anxiety. J Psychopharmacol. 2011, 25:1415-33. 10.1177\/0269881110367726","journal-title":"J Psychopharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2009.06.004","article-title":"The role of beta-endorphin in the pathophysiology of major depression","volume":"43","author":"Hegadoren KM","year":"2009","unstructured":"Hegadoren KM, O'Donnell T, Lanius R, Coupland NJ, Lacaze-Masmonteil N. The role of beta-endorphin in the pathophysiology of major depression. Neuropeptides. 2009, 43:341-53. 10.1016\/j.npep.2009.06.004","journal-title":"Neuropeptides"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00036","article-title":"Diverse roles of neurotensin agonists in the central nervous system","volume":"4","author":"Boules M","year":"2013","unstructured":"Boules M, Li Z, Smith K, Fredrickson P, Richelson E. Diverse roles of neurotensin agonists in the central nervous system. Front Endocrinol (Lausanne). 2013, 4:36. 10.3389\/fendo.2013.00036","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108005","article-title":"Neurotensin in reward processes","volume":"167","author":"Torruella-Su\u00e1rez ML","year":"2020","unstructured":"Torruella-Su\u00e1rez ML, McElligott ZA. Neurotensin in reward processes. Neuropharmacology. 2020, 167:108005. 10.1016\/j.neuropharm.2020.108005","journal-title":"Neuropharmacology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2019.152114","article-title":"Plasma neuropeptides as circulating biomarkers of multifactorial schizophrenia","volume":"94","author":"Ni P","year":"2019","unstructured":"Ni P, Tian Y, Gu X, et al.. Plasma neuropeptides as circulating biomarkers of multifactorial schizophrenia. Compr Psychiatry. 2019, 94:152114. 10.1016\/j.comppsych.2019.152114","journal-title":"Compr Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/joor.12977","article-title":"Daytime changes of salivary biomarkers involved in pain","volume":"47","author":"Jasim H","year":"2020","unstructured":"Jasim H, Ghafouri B, Carlsson A, Hedenberg-Magnusson B, Ernberg M. Daytime changes of salivary biomarkers involved in pain. J Oral Rehabil. 2020, 47:843-50. 10.1111\/joor.12977","journal-title":"J Oral Rehabil"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering10020258","article-title":"Protective role and functional engineering of neuropeptides in depression and anxiety: an overview","volume":"10","author":"Okdeh N","year":"2023","unstructured":"Okdeh N, Mahfouz G, Harb J, et al.. Protective role and functional engineering of neuropeptides in depression and anxiety: an overview. Bioengineering (Basel). 2023, 10:258. 10.3390\/bioengineering10020258","journal-title":"Bioengineering (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12304","article-title":"Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: a multiplex immunoassay study","volume":"43","author":"Hidese S","year":"2023","unstructured":"Hidese S, Yoshida F, Ishida I, Matsuo J, Hattori K, Kunugi H. Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: a multiplex immunoassay study. Neuropsychopharmacol Rep. 2023, 43:57-68. 10.1002\/npr2.12304","journal-title":"Neuropsychopharmacol Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14050492","article-title":"Specific salivary neuropeptides shift synchronously during acute stress in fire recruits","volume":"14","author":"Ryznar R","year":"2024","unstructured":"Ryznar R, Andrews N, Emery K, Snow M, Payton M, Towne F, Gubler D. Specific salivary neuropeptides shift synchronously during acute stress in fire recruits. Brain Sci. 2024, 14:492. 10.3390\/brainsci14050492","journal-title":"Brain Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s40359-022-00744-5","article-title":"Depressive symptomatology, temperament and oxytocin serum levels in a sample of healthy female university students","volume":"10","author":"Veiga L","year":"2022","unstructured":"Veiga L, Carolino E, Santos I, et al.. Depressive symptomatology, temperament and oxytocin serum levels in a sample of healthy female university students. BMC Psychol. 2022, 10:36. 10.1186\/s40359-022-00744-5","journal-title":"BMC Psychol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.28982\/josam.922612","article-title":"Evaluation of serum oxytocin levels in patients with depression, generalized anxiety disorder, panic disorder, and social anxiety disorder: a case-control study","volume":"5","author":"Tuman TC","year":"2021","unstructured":"Tuman TC, Yildirim O, Irmak A, Tufan AE, Camkurt MA. Evaluation of serum oxytocin levels in patients with depression, generalized anxiety disorder, panic disorder, and social anxiety disorder: a case-control study. J Surg Med. 2021, 5:670-5. 10.28982\/josam.922612","journal-title":"J Surg Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2010.01.006","article-title":"Involvement of alpha-MSH in the social isolation induced anxiety- and depression-like behaviors in rat","volume":"58","author":"Kokare DM","year":"2010","unstructured":"Kokare DM, Dandekar MP, Singru PS, Gupta GL, Subhedar NK. Involvement of alpha-MSH in the social isolation induced anxiety- and depression-like behaviors in rat. Neuropharmacology. 2010, 58:1009-18. 10.1016\/j.neuropharm.2010.01.006","journal-title":"Neuropharmacology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(13)75714-6","article-title":"Increase of beta-endorphin plasma level as a potential marker of positive response to treatment of depression","volume":"28","author":"Kubryak O","year":"2013","unstructured":"Kubryak O, Emelyanova I. Increase of beta-endorphin plasma level as a potential marker of positive response to treatment of depression. Eur Psychiatry. 2013, 28:10.1016\/S0924-9338(13)75714-6","journal-title":"Eur Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.07.021","article-title":"Interaction between serotonin 5-HT1A receptors and beta-endorphins modulates antidepressant response","volume":"32","author":"Navin\u00e9s R","year":"2008","unstructured":"Navin\u00e9s R, Mart\u00edn-Santos R, G\u00f3mez-Gil E, Mart\u00ednez de Osaba MJ, Gast\u00f3 C. Interaction between serotonin 5-HT1A receptors and beta-endorphins modulates antidepressant response. Prog Neuropsychopharmacol Biol Psychiatry. 2008, 32:1804-9. 10.1016\/j.pnpbp.2008.07.021","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2021.629729","article-title":"Neurotensin and xenin show positive correlations with perceived stress, anxiety, depressiveness and eating disorder symptoms in female obese patients","volume":"15","author":"W\u00f6lk E","year":"2021","unstructured":"W\u00f6lk E, Stengel A, Schaper SJ, Rose M, Hofmann T. Neurotensin and xenin show positive correlations with perceived stress, anxiety, depressiveness and eating disorder symptoms in female obese patients. Front Behav Neurosci. 2021, 15:629729. 10.3389\/fnbeh.2021.629729","journal-title":"Front Behav Neurosci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.134","article-title":"A key role for neurotensin in chronic-stress-induced anxiety-like behavior in rats","volume":"43","author":"Normandeau CP","year":"2018","unstructured":"Normandeau CP, Ventura-Silva AP, Hawken ER, et al.. A key role for neurotensin in chronic-stress-induced anxiety-like behavior in rats. Neuropsychopharmacology. 2018, 43:285-93. 10.1038\/npp.2017.134","journal-title":"Neuropsychopharmacology"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2009.01936.x","article-title":"Plasma and cerebrospinal fluid substance P in post-stroke patients with depression","volume":"63","author":"Li L","year":"2009","unstructured":"Li L, Gao X, Zhao J, Ji X, Wei H, Luo Y. Plasma and cerebrospinal fluid substance P in post-stroke patients with depression. Psychiatry Clin Neurosci. 2009, 63:298-304. 10.1111\/j.1440-1819.2009.01936.x","journal-title":"Psychiatry Clin Neurosci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/279117-analysis-of-salivary-neuropeptides-in-anxiety-and-depression-using-the-luminex-magpix-system","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:01:54Z","timestamp":1724828514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/279117-analysis-of-salivary-neuropeptides-in-anxiety-and-depression-using-the-luminex-magpix-system"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.67984","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,28]]}}}